Nausea, vomiting, diarrhea, constipation, pancreatitis symptoms, gallbladder problems, and potential thyroid concerns are the main issues discussed in clinical literature
With skyrocketing demand has come skyrocketing prices, however, and neither the demand for these prescriptions nor their price points appear likely to come down any time soon
The risk of thyroid cancer doesnt seem to appear until about the 1-3 year mark
To sum up, GLP-1 receptor agonists protect neurons through several pathways including the classic cAMP/PKA/CREB pathway, the PI3K/Akt pathway, controlling inflammation, and keeping mitochondria working as shown in Figure 1
Each small change adds up